Cargando…

Peptide Receptor Targeting in Cancer: The Somatostatin Paradigm

Peptide receptors involved in pathophysiological processes represent promising therapeutic targets. Neuropeptide somatostatin (SST) is produced by specialized cells in a large number of human organs and tissues. SST primarily acts as inhibitor of endocrine and exocrine secretion via the activation o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barbieri, Federica, Bajetto, Adriana, Pattarozzi, Alessandra, Gatti, Monica, Würth, Roberto, Thellung, Stefano, Corsaro, Alessandro, Villa, Valentina, Nizzari, Mario, Florio, Tullio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582104/ https://www.ncbi.nlm.nih.gov/pubmed/23476673 http://dx.doi.org/10.1155/2013/926295

Ejemplares similares

Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells
por: Corsaro, Alessandro, et al.
Publicado: (2016)

Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity
por: Thellung, Stefano, et al.
Publicado: (2019)

Role of Prion Protein Aggregation in Neurotoxicity
por: Corsaro, Alessandro, et al.
Publicado: (2012)

Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System
por: Barbieri, Federica, et al.
Publicado: (2014)

Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors
por: Bajetto, Adriana, et al.
Publicado: (2017)

Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells
por: Würth, Roberto, et al.
Publicado: (2020)

Neurodegeneration in Alzheimer Disease: Role of Amyloid Precursor Protein and Presenilin 1 Intracellular Signaling
por: Nizzari, Mario, et al.
Publicado: (2012)

Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets
por: Thellung, Stefano, et al.
Publicado: (2022)

In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors
por: Barbieri, Federica, et al.
Publicado: (2015)

Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies
por: Bajetto, Adriana, et al.
Publicado: (2020)

Pharmacological activation of autophagy favors the clearing of intracellular aggregates of misfolded prion protein peptide to prevent neuronal death
por: Thellung, Stefano, et al.
Publicado: (2018)

CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment
por: Würth, Roberto, et al.
Publicado: (2014)

Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms
por: Gatto, Federico, et al.
Publicado: (2019)

Role of Chemokine Network in the Development and Progression of Ovarian Cancer: A Potential Novel Pharmacological Target
por: Barbieri, Federica, et al.
Publicado: (2010)

Emerging Role of Cellular Prion Protein in the Maintenance and Expansion of Glioma Stem Cells †
por: Thellung, Stefano, et al.
Publicado: (2019)

Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell Viability
por: Barbieri, Federica, et al.
Publicado: (2018)

CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis
por: Ferrari, Angelo, et al.
Publicado: (2012)

Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells
por: Angeletti, Francesca, et al.
Publicado: (2016)

Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives
por: Barbieri, Federica, et al.
Publicado: (2022)

The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells
por: Pattarozzi, Alessandra, et al.
Publicado: (2017)

New Molecules and Old Drugs as Emerging Approaches to Selectively Target Human Glioblastoma Cancer Stem Cells
por: Würth, Roberto, et al.
Publicado: (2014)

Human PrP90-231-induced cell death is associated with intracellular accumulation of insoluble and protease-resistant macroaggregates and lysosomal dysfunction
por: Thellung, S, et al.
Publicado: (2011)

Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current
por: Gritti, Marta, et al.
Publicado: (2014)

Calcium Binding Promotes Prion Protein Fragment 90–231 Conformational Change toward a Membrane Destabilizing and Cytotoxic Structure
por: Sorrentino, Sacha, et al.
Publicado: (2012)

Efficacy of a Three Drug-Based Therapy for Neuroblastoma in Mice
por: Garbati, Patrizia, et al.
Publicado: (2021)

Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST(2) in Mediating Ligand Effects
por: Amarù, Jessica, et al.
Publicado: (2021)

Ruta graveolens L. Induces Death of Glioblastoma Cells and Neural Progenitors, but Not of Neurons, via ERK 1/2 and AKT Activation
por: Gentile, Maria Teresa, et al.
Publicado: (2015)

Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects
por: Baldassari, Sara, et al.
Publicado: (2018)

MCM2 and Carbonic Anhydrase 9 Are Novel Potential Targets for Neuroblastoma Pharmacological Treatment
por: Garbati, Patrizia, et al.
Publicado: (2020)

Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?
por: Mohamed, Amira, et al.
Publicado: (2017)

An intronic ncRNA-dependent regulation of SORL1 expression affecting Aβ formation is upregulated in post-mortem Alzheimer's disease brain samples
por: Ciarlo, Eleonora, et al.
Publicado: (2013)

The inhibition of 45A ncRNA expression reduces tumor formation, affecting tumor nodules compactness and metastatic potential in neuroblastoma cells
por: Penna, Ilaria, et al.
Publicado: (2016)

Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity
por: Barbieri, Federica, et al.
Publicado: (2019)

Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA
por: Costa, Delfina, et al.
Publicado: (2014)

Histone Deacetylase Inhibitors Impair Vasculogenic Mimicry from Glioblastoma Cells
por: Pastorino, Olga, et al.
Publicado: (2019)

Voltage-Gated Sodium Channel Dysfunctions in Neurological Disorders
por: Barbieri, Raffaella, et al.
Publicado: (2023)

In vitro study of uptake and synthesis of creatine and its precursors by cerebellar granule cells and astrocytes suggests some hypotheses on the physiopathology of the inherited disorders of creatine metabolism
por: Carducci, Claudia, et al.
Publicado: (2012)

Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms
por: Borgna, Francesca, et al.
Publicado: (2021)

Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits
por: Stella, Manuela, et al.
Publicado: (2023)

Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells
por: Rossi, Valentina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_otb8q8rgbc8gt17srv76squktp